Skip to main content

TCG — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

147
Companies
$1.7B
Total invested
$31.7M
Avg. check
36
Industries
Biotechnology 11Therapeutics 8Health Care 8Pharmaceutical 5Medical 5Gaming 4+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 147
Avalo Therapeutics
May 2026

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Biotechnology · Rockville$431.3M Post-IPO Equity
Mirum Pharmaceuticals
May 2026

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Biotechnology · Foster City$600.0M Post-IPO Debt
Branch
May 2022

Branch is where creative rebels thrive, games evolve, and players shape the journey.

Gaming · Seattle$12.5M Seed
Ready Player DAO
April 2022

is a Web3 gaming DAO that empowers players and creators through blockchain gaming, NFTs, and decentralized play-to-earn ecosystems.

Blockchain · Dover$10.2M Venture - Series Unknown
Valneva
April 2026

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Biotechnology · Saint-herblain$43.1M Post-IPO Equity
Maze Therapeutics
April 2026

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Biopharma · South San Francisco$150.0M Post-IPO Equity
ADCendo
April 2026

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Biotechnology · Copenhagen$75.0M Series C
Real Sports App
April 2026

Real Sports App is a social sports data platform that engages fans around every live sports moment.

Apps · Chicago$12.1M Venture - Series Unknown
AN2 Therapeutics
March 2026

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Biotechnology · Menlo Park$40.0M Post-IPO Equity
Vor Biopharma
March 2026

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Biotechnology · Cambridge$75.0M Post-IPO Equity
Inhibrx
March 2026

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Biopharma · La Jolla$75.0M Post-IPO Debt
Arbor Biotechnologies
March 2025

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Artificial Intelligence (AI) · Cambridge$73.9M Series C
Altered State Machine
March 2022

Altered State Machine is a new protocol for non fungible intelligence.

Artificial Intelligence (AI) · Auckland$11.0M Seed
audiochuck
February 2025

audiochuck is a media company that creates and produces content.

Digital Media · Indianapolis$40.0M Private Equity
Perspective Therapeutics
February 2026

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Health Care · Seattle$175.0M Post-IPO Equity
Stoggles
February 2022

Stoggles is eyewear that does everything for people who do everything.

Consumer Goods · Paramount$40.0M Venture - Series Unknown
RabbitHole
February 2022

Earn crypto by using the latest crypto applications.

Cryptocurrency · Venice$18.0M Series A
Immunic Therapeutics
February 2026

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Biotechnology · New York$400.0M Post-IPO Equity
ADARx Pharmaceuticals
February 2025

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Biotechnology · San DiegoVenture - Series Unknown
Galaxy Fight Club
February 2022

Galaxy Fight Club is a cross-IP, cross-platform PvP fighting game for different NFT collectors to battle with each other to earn rewards.

Gaming · Delaware City$7.0M Seed
Equip Health
July 2025

Equip Health provides a virtual eating disorder treatment program designed to assist families recover from eating disorders at home.

Fitness · San Diego$46.6M Venture - Series Unknown
Substack
July 2025

Substack is a subscription-based newsletter publishing platform for independent writers.

Content Creators · San Francisco$100.0M Series C
Sphere
December 2024

The operating system for stablecoins.

B2B · Boston$5.0M Venture - Series Unknown
Curio
August 2024

Curio is bringing competitive gameplay to real money games, starting with Duper.

Gaming · San Francisco$5.7M Seed

Where TCG invests

Biotechnology11
Therapeutics8
Health Care8
Pharmaceutical5
Medical5
Gaming4

About TCG's portfolio

How many companies has TCG invested in?

TCG has invested in 147 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does TCG invest in?

TCG's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Medical. The firm invests across 36 different industry categories.

What is TCG's largest investment?

Among tracked funding rounds, Mirum Pharmaceuticals received $600.0M in a Post-IPO Debt round. TCG's total known invested capital is $1.7B.

What is the average investment size for TCG?

TCG's average investment size is $31.7M across its portfolio of 147 companies.

What are TCG's most recent investments?

Recent TCG portfolio additions include Avalo Therapeutics, Mirum Pharmaceuticals, Branch, Ready Player DAO, Valneva. These companies were founded in 2020 or later.

Reach the founders behind these 147 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →